No Data
No Data
Guobang Pharmaceutical (605507.SH): Repurchased 1.1% of the shares.
On July 31st, Gelunhui reported that Guobangyiyao (605507.SH) has accumulated a repurchase of 6,127,000 shares through centralized auction trading until July 31, 2024. The repurchased shares account for 1.10% of the company's total share capital, with the highest transaction price of 18.66 yuan/share and the lowest price of 13.05 yuan/share. The total amount paid is 99,515,878.00 yuan (excluding transaction costs).
Guobang Pharma (605507.SH): The first phase employee stock ownership plan has purchased a cumulative 0.23% share.
On July 30th, Gelon Hui reported that Guobang Medicine (605507.SH) has announced that as of the date of this announcement, the first phase of the company's employee stock ownership plan has cumulatively purchased 1,277,300 shares of the company's stocks through the secondary market, accounting for 0.23% of the company's total share capital, with an average transaction price of 16.01 yuan/share and a transaction amount of 20,447,449.00 yuan (excluding transaction costs).
Is Guobang Pharma Ltd.'s (SHSE:605507) Stock Price Struggling As A Result Of Its Mixed Financials?
Guobang Pharmaceutical (605507.SH): Cumulative repurchase of 1.10% of shares.
On July 1st, Gelon Hui reported that Guobang Medicine (605507.SH) has repurchased a total of 6,127,000 shares through concentrated bidding trading method as of June 30, 2024. The repurchased shares account for 1.10% of the company's total share capital, with the highest transaction price of 18.66 CNY/share and the lowest transaction price of 13.05 CNY/share. The total amount paid was 99,515,878.00 CNY (excluding transaction costs).
Guobang Pharmaceutical (605507.SH) plans to launch the first phase of employee shareholding plan.
On June 27th, Gelunhui, Guobang Medicine (605507.SH) announced the first phase of the employee stock ownership plan. The initial total amount of funds raised for this employee stock ownership plan will not exceed 125 million yuan, of which the employee self-raised funds will not exceed 125 million yuan, and the specific amount will be determined according to the actual contribution payment. The total number of stocks involved in this employee stock ownership plan does not exceed 10% of the total share capital of the company, and the total number of stocks corresponding to the share of any employee stock ownership plan held by any holder does not exceed 1% of the total share capital of the company. The total number of people does not exceed 260, including directors who participate in the stock ownership plan.
Guobang Pharma Ltd.'s (SHSE:605507) Share Price Is Matching Sentiment Around Its Earnings
No Data